Abstract:BACKGROUND:Early investigation suggested patients' level of awareness regarding clinical trials was related with willingness to participation. This study was intended to evaluate the level of awareness of cancer patients regarding clinical trials and related influencing factors, and to compare the differences of awareness between patients who attended clinical trials before and not.METHODS:From Jun, 2018 to April, 2019, standardized question-naires were gathered from cancer patients (attended clinical trials vs not attended clinical trials) in our hospital regarding basic information and 10 other questions about awareness. The level of awareness was evaluated and patients were classified into "low cognition" and "high cognition" groups. Logistic regression analysis was performed to determine whether certain characteristics would predict for awareness.RESULTS:Of the 617 participants, 38.6% have attended clinical trials before. 338 (54.6%) patients had a correct overall understanding of clinical trials, while 44 (7.1%) patients still thought participants were the victim of scientific research. Except for the compensation of medical expenses (51.5% vs 48.7%) and related laws of clinical trials (52.3% vs 45.5%), other parts of understanding were elevated in patients attended clinical trials before comparing with patients who didn't, including significance (86.2% vs 77.6%), risk disclosure (91.2% vs 71.6%), confidentiality (73.2% vs 59.7%), voluntariness (95.8% vs 76.3%), withdrawal (86.6% vs 68.2%) and expenses (62.8% vs 39.2%). The proportion of participants who understand these components did not increase even in 239 patients who had attended clinical trials before. Participants who attended clinical trials before (OR=1.83, 95%CI: 1.11-3.00), unmarried/divorced (OR=5.04, 95%CI: 1.73-14.66), retired (OR=2.53, 95%CI: 1.16-5.50) had a higher level of awareness, while patients who had bad impression with doctors (OR=0.43, 95%CI: 0.26-0.72) had lower awareness.CONCLUSIONS:The current level of awareness for clinical trials of cancer patients in our hospital was relatively low, even in patients who had attended clinical trials before. It's necessary to improve patients' awareness of clinical trial by promoting harmony relationship between patients and doctors, as well as by enhancing related propagation. Strengthening the adequacy and efficacy of informed consent in clinical trials also needs to be achieved in the future.

Is Therapeutic Non-Disclosure Still Possible? A Study on the Awareness of Cancer Diagnosis in China

A qualitative study on the attitudes of patients with gastrointestinal cancer toward being informed of the truth.

Why do oncologists hide the truth? Disclosure of cancer diagnoses to patients in China: A multisource assessment using mixed methods.

When Clinicians Telling the Truth is De Facto Discouraged, What is the Family’s Attitude Towards Disclosing to a Relative Their Cancer Diagnosis?

Different Attitudes of Chinese Patients and Their Families Toward Truth Telling of Different Stages of Cancer

Whether, When, and Who to Disclose Bad News to Patients with Cancer: a Survey in 150 Pairs of Hospitalized Patients with Cancer and Family Members in China.

To Tell Or Not To Tell: Attitudes Of Chinese Oncology Nurses Towards Truth Telling Of Cancer Diagnosis

Psychological Morbidity and Health‐related Quality of Life in Patients with Differing Awareness of Cancer Diagnosis: a Cross‐sectional Study

Perspectives of Chinese Cancer Patients Toward Disclosure of Cancer Diagnosis to Their Minor Children

Different Attitudes of Oncology Clinicians Toward Truth Telling of Different Stages of Cancer

Cancer Stages: What Do Chinese Cancer Patients Know?

How doctors communicate the initial diagnosis of cancer matters: cancer disclosure and its relationship with Patients' hope and trust

Informing or concealing - Dynamics of telling disease-related bad news among family members of older cancer patients: A qualitative study

[Awareness and Influencing Factors of Clinical Trial among Cancer Patients in China].

Conspiracy of Silence in Head and Neck Cancer Diagnosis: A Scoping Review

Truth Telling for Patients with Esophageal Squamous Cell Carcinoma in Henan, China

Knowledge of a cancer diagnosis is a protective factor for the survival of patients with breast cancer: a retrospective cohort study

Cancer Diagnosis Disclosure and Quality of Life in Elderly Cancer Patients

Investigation on Requirements and Influencing Factors of Disclosure Strategy for Cancer Patients

Predicaments and coping strategies in implementing cancer truth-telling: a qualitative content analysis

Cross-cultural issues in the disclosure of cancer